Natural Biocon (India) Board of Directors

Get the latest insights into the leadership at Natural Biocon (India). Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Arunkumar Prajapati Chairman & Managing Director
Mr. Suryakant Lohar Independent Director
Mrs. Darshangi Patel Independent Director
Mr. Bhaskar Vishe Independent Director

Natural Biocon (India) Share price

NATURAL

7.48

0.26 (-3.36%)
Last updated on 4 Sep, 2025 | 15:55 IST
BUYSELL
Today's High

7.90

Today's Low

7.43

52 Week Low

7.43

52 Week High

18.30

The current prices are delayed, login to your account for live prices

Natural Biocon (India) FAQs

The board at Natural Biocon (India) consists of experienced professionals, including Mr. Arunkumar Prajapati , Mr. Suryakant Lohar , and others, overseeing the company’s strategic and corporate governance.

Directors at Natural Biocon (India) are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Arunkumar Prajapati is the current chairman at Natural Biocon (India).

Executive directors at Natural Biocon (India) are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Natural Biocon (India) adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Natural Biocon (India), board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.